Recently, Chen et al. [36] suggested that GLP-1 receptor agonist can protect neurons from diabetes-associated glucose metabolic dysregulation insults in vitro and from ICV streptozotocin insult in vivo. Here, GLP1R is linked to diabetes mellitus.